TScan Therapeutics says CFO Jason Amello steps down in reorganization
TCRX•TScan Therapeutics said CFO Jason Amello and Chief Medical Officer Chrystal Louis will step down in a strategic reorganization, with both employees’ departures scheduled by Nov. 1, 2026.
1. Executive departures
TScan Therapeutics disclosed planned executive departures tied to a strategic reorganization. CFO Jason A. Amello and Chief Medical Officer Chrystal Louis, M.D., MPH, will step down, with their employment ending by Nov. 1, 2026.
